ClearPoint Neuro

CLPT56

$11.45arrow_drop_down7.66%-$0.95

CLPT56

$11.45

arrow_drop_down7.66%-$0.95

Performance History

Key Stats
Open	$12.39
Prev. Close	$12.40
EPS	-0.70
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	11.45	12.39
52 Week Range	4.05	13.47

Ratios







EPS	-0.70

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About ClearPoint Neuro (CLPT)

ClearPoint Neuro Inc (CLPT) is a medical technology company focused on developing and commercializing innovative solutions for the neurosurgery market. The company's primary product is the ClearPoint Neuro Navigation System, which is designed to provide real-time MRI-guided navigation for precise targeting and placement of neurosurgical devices. This technology allows surgeons to perform minimally invasive procedures with improved accuracy and patient outcomes.

With a market cap of $XXX billion, ClearPoint Neuro is a small-cap company operating in the healthcare sector. The company's stock, CLPT, has seen fluctuating performance over the past year, with a 52-week range of $X to $X. As of the latest trading session, the stock traded within a day range of $X to $X. The trading volume for CLPT has been moderate, indicating a reasonable level of investor interest in the stock.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Joseph Michael Burnett
Headquarters: Solana Beach
Employees: 108
Exchange: NASDAQ

Keep an eye on ClearPoint Neuro

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is ClearPoint Neuro 's (CLPT) price per share?

The current price per share for ClearPoint Neuro (CLPT) is $11.45. The stock has seen a price change of -$0.95 recently, indicating a -7.66% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for ClearPoint Neuro (CLPT)?

For ClearPoint Neuro (CLPT), the 52-week high is $13.47, which is 17.64% from the current price. The 52-week low is $4.05, the current price is 182.72% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is ClearPoint Neuro (CLPT) a growth stock?

ClearPoint Neuro (CLPT) has shown an average price growth of 0.41% over the past three years. It has received a score of 17 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ClearPoint Neuro as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is ClearPoint Neuro (CLPT) stock price performance year to date (YTD)?

As of the latest data, ClearPoint Neuro (CLPT) has a year-to-date price change of 69.38%. Over the past month, the stock has experienced a price change of 0.7%. Over the last three months, the change has been 107.8%. Over the past six months, the figure is 74.28%.

help

Is ClearPoint Neuro (CLPT) a profitable company?

ClearPoint Neuro (CLPT) has a net income of -$22.09M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.83% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -60.31% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $23.96M, with a revenue growth rate of 16.56%, providing insight into the company's sales performance and growth. The gross profit is $13.61M. Operating income is noted at -$22.45M. Furthermore, the EBITDA is -$17.76M.

help

What is the market capitalization of ClearPoint Neuro (CLPT)?

ClearPoint Neuro (CLPT) has a market capitalization of $342.19M. The average daily trading volume is 190.23K, indicating the stock's liquidity and investor engagement.

News

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

PARTNERSHIPS

CLINICAL STUDY

6/20/2024

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial